Scientists and clinicians at TRI are working towards improved diagnosis and treatment of various cancers including breast, prostate, head and neck, and skin cancers.

In 2018, an estimated 140,000 new cases of cancer were diagnosed, and just under 50,000 people died from the disease (AIHW, 2018). In Australia, the most commonly diagnosed cancers are currently breast cancer, followed by prostate cancer, colorectal cancer and melanoma.(AIHW, 2018

Researchers at TRI are working closely with clinicians to identify novel ways to detect, diagnose, monitor and treat various types of cancers. These projects include specialist cancer groups across QUT's Institute of Health and Biomedical Innovation, Mater Research, The University of Queensland.

Image: Cancer tumour spheroid with fluorescent labelling according to cell phenotype. Crystal Tonnessen (June 2015).

Key Researchers
Andrew Perkins
Nicholas Andrew Saunders
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Show More ...
Click a program below to learn more
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Interview with Prof John Hooper about pancreatic cancer research
Fresh tumour biopsies in world-first technique for cancer treatments University of Queensland researchers have developed an innovative technique to help pharmaceutical and technology companies design...Read more
Researchers optimising cancer survivors’ outcomes Brisbane cancer nurse scientists are working alongside clinicians and scientists to develop better healthcare models for cancer survivors. QUT...Read more
Improving genetic testing for skin cancer Genetic researcher and counsellor, Dr Aideen McInerney-Leo is leading a series of multifaceted studies aimed at improving genetic testing for skin cancer ...Read more
TRI-based Mater researchers in partnership with The University of Queensland have developed a new cancer vaccine, which has shown promising signs in preclinical laboratory studies. Funded by grants...Read more
A lifetime dedicated to prostate and bladder cancer research A new, targeted antibody-based treatment and diagnostic for prostate and bladder cancers is one of several important outcomes from the...Read more
Research at TRI is helping advance regenerative medicine, tissue engineering and cell therapies to overcome the health burden associated with ageing populations and increasing chronic disease...Read more
Brisbane scientists have found that eating a high-fat diet over a long period-of-time may induce early Barrett’s oesophagus, a precursor condition to oesophageal cancer. TRI awarded a 2015...Read more
TRI researchers have received vital funding from the Australian Government to trial a new diagnostic for epithelial ovarian cancer (EOC), the first study of its kind in humans. Mater Research...Read more
A new research grant will help researchers better understand and potentially treat prostate cancer, which has spread to the bones. Cure Cancer Australian, Cancer Australia and the Can Too Foundation...Read more
An arsenal of proteins used by many cell types to communicate with and control other cells could hold the answers to treating a multitude of diseases, especially cancer. The University of Queensland...Read more